Literature DB >> 32832501

Nonalcoholic fatty liver disease in type 2 diabetes: awareness is the first step toward change.

Fernando Bril1,2.   

Abstract

Entities:  

Year:  2020        PMID： 32832501      PMCID： PMC7423547          DOI： 10.21037/hbsn.2019.11.11

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  16 in total

1.  Prevalence of fatty liver in children and adolescents.

Authors:  Jeffrey B Schwimmer; Reena Deutsch; Tanaz Kahen; Joel E Lavine; Christina Stanley; Cynthia Behling
Journal:  Pediatrics       Date:  2006-10       Impact factor: 7.124

2.  Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients.

Authors:  Giovanni Targher; Lorenzo Bertolini; Stefano Rodella; Roberto Tessari; Luciano Zenari; Giuseppe Lippi; Guido Arcaro
Journal:  Diabetes Care       Date:  2007-05-22       Impact factor: 19.112

3.  Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Paul Angulo; David E Kleiner; Sanne Dam-Larsen; Leon A Adams; Einar S Bjornsson; Phunchai Charatcharoenwitthaya; Peter R Mills; Jill C Keach; Heather D Lafferty; Alisha Stahler; Svanhildur Haflidadottir; Flemming Bendtsen
Journal:  Gastroenterology       Date:  2015-04-29       Impact factor: 22.682

4.  Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort.

Authors:  Veronica Wendy Setiawan; Daniel O Stram; Jacqueline Porcel; Shelly C Lu; Loïc Le Marchand; Mazen Noureddin
Journal:  Hepatology       Date:  2016-07-17       Impact factor: 17.425

Review 5.  4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes-2019.

Authors: 
Journal:  Diabetes Care       Date:  2019-01       Impact factor: 19.112

Review 6.  Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.

Authors:  Parambir S Dulai; Siddharth Singh; Janki Patel; Meera Soni; Larry J Prokop; Zobair Younossi; Giada Sebastiani; Mattias Ekstedt; Hannes Hagstrom; Patrik Nasr; Per Stal; Vincent Wai-Sun Wong; Stergios Kechagias; Rolf Hultcrantz; Rohit Loomba
Journal:  Hepatology       Date:  2017-03-31       Impact factor: 17.425

Review 7.  Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action.

Authors:  Fernando Bril; Kenneth Cusi
Journal:  Diabetes Care       Date:  2017-03       Impact factor: 19.112

8.  Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.

Authors:  Jeffrey D Browning; Lidia S Szczepaniak; Robert Dobbins; Pamela Nuremberg; Jay D Horton; Jonathan C Cohen; Scott M Grundy; Helen H Hobbs
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

9.  The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis.

Authors:  Zobair M Younossi; Pegah Golabi; Leyla de Avila; James Minhui Paik; Manirath Srishord; Natsu Fukui; Ying Qiu; Leah Burns; Arian Afendy; Fatema Nader
Journal:  J Hepatol       Date:  2019-07-04       Impact factor: 25.083

Review 10.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425
View more
  2 in total

Review 1.  PPAR-Targeted Therapies in the Treatment of Non-Alcoholic Fatty Liver Disease in Diabetic Patients.

Authors:  Naomi F Lange; Vanessa Graf; Cyrielle Caussy; Jean-François Dufour
Journal:  Int J Mol Sci       Date:  2022-04-13       Impact factor: 6.208

2.  Exercise and Metformin Intervention Prevents Lipotoxicity-Induced Hepatocyte Apoptosis by Alleviating Oxidative and ER Stress and Activating the AMPK/Nrf2/HO-1 Signaling Pathway in db/db Mice.

Authors:  Yuan Zhang; Yuting Liu; Xiaowei Liu; Xinmeng Yuan; Mengqi Xiang; Jingjing Liu; Liumei Zhang; Shouqian Zhu; Jiao Lu; Qiang Tang; Sulin Cheng
Journal:  Oxid Med Cell Longev       Date:  2022-09-09       Impact factor: 7.310
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.